www.fdanews.com/articles/122793-gentium-says-therapy-promising-in-treating-preventing-vod
Gentium Says Therapy Promising in Treating, Preventing VOD
December 8, 2009
Italian Biopharma company Gentium S.p.A. said its Defibrotide therapy shows
a strong trend toward statistical significance in the prevention and treatment of Hepatic Veno-Occlusive Disease or VOD, a potentially life-threatening
condition that typically occurs as an important complication of stem cell transplantation.
RTTNews
RTTNews